시장보고서
상품코드
2104604

착상전 유전자 검사 시장 : 제품별, 용도별, 최종사용자별, 기술별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

Preimplantation Genetic Testing Market, By Product, By Application, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,633,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,500,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,054,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

착상전 유전자 검사 시장 규모는 2025년에 8억 3,040만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 9.8%로 확대될 것으로 전망됩니다.

착상전 유전자 검사(PGT) 시장에는 체외수정(IVF)을 통해 생성된 배아를 선별하여 염색체 이상, 유전성 질환 및 염색체 재편성을 검출하기 위한 유전자 검사 기술의 활용이 포함됩니다. 착상전 유전자 검사(PGT)를 통해 유전학적 관점에서 건강한 배아를 선별할 수 있게 되어, 이를 통해 체외수정(IVF)의 성공률을 높이는 동시에 유전성 질환의 전달 위험 및 유산 위험을 최소화할 수 있습니다.

이 시장은 유전성 질환 발생률 증가, 불임률 상승, 여성의 고령화, 그리고 보조생식기술(ART)의 보급으로 인해 급속한 성장을 보이고 있습니다. 차세대 염기서열 분석(NGS), 중합효소 연쇄 반응(PCR), 및 마이크로어레이 기술의 발전은 배아 선별유효성을 높이는 데 기여하고 있습니다. 또한, 생식 유전학에 대한 인식 제고, 불임 치료에 대한 정부의 지원, 정밀 의학에 대한 투자가 전 세계 착상전 유전자 검사 시장의 추가적인 성장에 기여할 것으로 보입니다.

착상전 유전자 검사 시장 - 시장 역학

보조생식기술(ART)의 이용 확대가 착상전 유전자 검사 시장의 성장을 견인

보조생식기술(ART)의 이용 확대는 PGT 시장의 확장에 기여하는 주요 요인 중 하나입니다. 출산 연령의 고령화, 생활 방식의 변화, 비만, 생식기 질환 등으로 인한 불임 발생률 증가에 따라 체외수정(IVF) 치료를 원하는 부부가 증가하고 있습니다. PGT는 배아 이식 전에 염색체 이상, 단일 유전자 질환 및 구조적 염색체 재배열을 식별할 수 있는 능력을 통해 체외수정(IVF)의 중요한 일부로 부상해 왔습니다. 이는 배아 선별을 개선하고, 착상률을 높이며, 자연 유산의 위험을 낮추고, 자손에게 유전성 질환이 전달될 위험을 줄이는 데 도움이 됩니다.

유럽인간생식·배아학회(ESHRE)에 따르면, 유럽 전역에서 연간 100만 건 이상의 보조생식기술(ART) 치료 주기가 시행되고 있으며, 이는 보조생식기술의 보급이 확대되고 있고, 첨단 배아 유전자 선별에 대한 수요가 증가하고 있음을 보여줍니다. 또한, 차세대 염기서열 분석(NGS) 및 PCR 기술 분야의 지속적인 발전으로 PGT의 정확도와 속도가 향상되고 있습니다. 아울러 생식 유전학에 대한 인식이 높아지는 데 더해, 불임 치료 클리닉의 확대와 일부 국가의 유리한 규제 환경이 PGT 서비스 이용 확대를 뒷받침하고 있습니다. 체외수정(IVF) 주기의 증가와 맞춤형 생식 의료 서비스에 대한 수요 증대가 향후 몇 년간 착상전 유전자 검사 시장을 견인할 것으로 예상됩니다.

착상전 유전자 검사 시장 - 세분화 분석:

전 세계 착상전 유전자 검사 시장은 제품, 용도, 최종사용자, 기술 및 지역을 기준으로 세분화되어 있습니다.

착상전 유전자 검사 시장에서 검사 유형별로 보면 염색체 이상을 검출하기 위해 체외수정(IVF) 치료 과정에서 널리 이용되고 있는 ‘착상 전 염색체 이상 검사(PGT-A)’ 서비스가 가장 큰 시장 점유율을 차지하고 있습니다. 이러한 유전자 검사는 특히 고령 여성의 경우 착상 가능성을 높이고, 유산 위험을 줄이며, 임신 가능성을 높여줍니다. 또한 차세대 염기서열 분석 기술의 활용 확대에 따라 PGT-A 검사 서비스의 효율성과 정확도가 향상되고 있습니다. 예를 들어, 2026년 5월 GenEmbryomics Limited는 체외수정(IVF) 배아에 사용되는 세계 최초의 임상 등급 전장 유전체 착상전 유전자 검사 솔루션인 ‘XGEN PGT-X(TM)’를 발표했습니다. 이는 합리적인 가격으로 종합적인 배아 유전체 시퀀싱을 제공하기 위해 해당 회사의 ‘얼리 액세스 파트너 프로그램’을 통해 이용 가능해졌습니다. 또한, 배아 착상 전 유전성 질환 선별을 목적으로 한 유전자 검사의 증가에 따라, PGT-M(단일 유전자 질환에 대한 착상전 유전자 검사) 검사 서비스는 향후 높은 성장이 예상됩니다.

용도별로는 전 세계 체외수정(IVF) 시술 건수의 증가와 임신 성공률 향상에 대한 관심이 높아짐에 따라, ‘체외수정 배아 선별’이 가장 큰 시장 점유율을 차지하고 있습니다. 또한, 생식 유전학이 불임 치료에 점점 더 통합됨에 따라 ‘유전성 질환 선별’, ‘반복 유산 예방’, ‘고급 생식 계획’의 도입도 증가하고 있습니다. 최종사용자별로는 전문 체외수정(IVF) 실험실, 첨단 배아 생검 기술 및 통합 유전자 검사 서비스를 이용할 수 있기 때문에 불임 치료 클리닉이 시장을 독점하고 있습니다. 기술별로는 차세대 염기서열 분석(NGS)이 높은 정확도, 확장성, 그리고 염색체 이상과 유전자 변이를 동시에 검출할 수 있는 능력 덕분에 가장 큰 시장 점유율을 차지하고 있으며, 현대의 착상전 유전자 검사에서 가장 선호되는 기술로 자리 잡고 있습니다.

착상전 유전자 검사 시장 - 지역별 분석

착상전 유전자 검사(PGT) 시장의 경우, 북미가 가장 큰 시장 점유율을 차지하고 있습니다. 이는 해당 지역의 보조생식기술(ART) 보급률이 높고, 첨단 유전자 검사 시설이 잘 갖춰져 있으며, 저명한 불임 치료 클리닉과 생식유전학 연구소가 존재하기 때문입니다. 또한, 유전성 질환에 대한 이해의 심화, 산모의 고령화, 그리고 체외수정(IVF)에서 차세대 염기서열 분석(NGS)에 기반한 배아 선별도입 확대도 시장 확대에 기여하는 요인으로 작용하고 있습니다. 미국 질병통제예방센터(CDC) 보고서에 따르면, 체외수정 치료에 대한 수요가 지속되고 있어 미국에서는 매년 꾸준히 많은 ART 시술이 이루어지고 있습니다. CDC의 ‘전미 ART 감시 시스템(NASS)’은 미국 내 약 500개의 불임 치료 클리닉으로부터 매년 데이터를 수집하고 있습니다. 이 시스템에 따르면, 2022년에는 약 43만 5,426건의 ART 주기가 시행되었습니다. ART 시술 건수의 증가에 따라 그 일환으로 PGT의 이용도 확대되고 있으며, 그 결과 북미는 세계 시장에서 주도적인 지역이 되었습니다.

유럽 또한 불임 치료를 위한 확립된 네트워크의 존재, 많은 국가에서의 지원적인 규제 환경, 그리고 생식 유전학 분야의 지속적인 기술 개발 덕분에 주요 시장 중 하나로 자리 잡고 있습니다. 특히 스페인, 영국, 이탈리아, 덴마크 등의 국가에서는 체외수정(IVF) 및 배아 선별 치료가 이용되는 사례가 증가하고 있습니다. 유럽에서는 매년 100만 건 이상의 ART 치료 주기가 시행되고 있으며, 이는 체외수정(IVF) 치료와 PGT-A, PGT-M, PGT-SR을 포함한 첨단 유전자 검사에 대한 수요가 증가하고 있음을 보여줍니다. 불임 치료 클리닉에서의 차세대 염기서열 분석(NGS) 검사 도입 확대는 해당 지역의 시장 성장을 더욱 촉진할 것으로 예상됩니다.

목차

제1장 착상전 유전자 검사 시장 개요

제2장 주요 요약

제3장 착상전 유전자 검사 주요 시장 동향

제4장 착상전 유전자 검사 산업 분석

제5장 착상전 유전자 검사 시장 : 높아지는 지정학적 긴장의 영향

제6장 착상전 유전자 검사 시장 구도

제7장 착상전 유전자 검사 시장 : 제품별

제8장 착상전 유전자 검사 시장 : 용도별

제9장 착상전 유전자 검사 시장 : 최종사용자별

제10장 착상전 유전자 검사 시장 : 기술별

제11장 착상전 유전자 검사 시장 : 지역별

제12장 주요 벤더 분석 : 착상전 유전자 검사 산업

제13장 AnalystView의 전방위 전망

KSM 26.08.06

Preimplantation Genetic Testing Market size was valued at US$ 830.4 Million in 2025, expanding at a CAGR of 9.8% from 2026 to 2033.

The Preimplantation Genetic Testing (PGT) Market includes the use of technologies for genetic testing that help screen the embryos that are produced via in vitro fertilization (IVF) in order to detect chromosomal anomalies, inheritable genetic disorders, and chromosome rearrangement. Preimplantation Genetic Testing (PGT) allows selecting healthy embryos from a genetic standpoint, thus boosting the chances of IVF success while minimizing the risks of transmission of genetic disorders and fetal losses.

The market demonstrates rapid growth due to the growing incidence of genetic disorders, increasing infertility levels, growing age of women, and the adoption of ART procedures. The advances in next generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies help boost the effectiveness of the embryo screening. Moreover, growing awareness of reproductive genetics, government support for fertility treatments, and investments in precision medicine should contribute to the further growth of the global Preimplantation Genetic Testing Market.

Preimplantation Genetic Testing Market- Market Dynamics

Rising Utilization of Assisted Reproductive Technologies Drives Preimplantation Genetic Testing Market Growth

The rising use of assisted reproductive technology (ART) forms one of the major factors contributing to the expansion of the PGT market. The growing incidence of infertility on account of delayed parenting, change in lifestyle choices, obesity, and reproductive diseases has resulted in more couples seeking treatment through in vitro fertilization (IVF). PGT has emerged as an important part of IVF through its ability to identify any chromosomal aberrations, single-gene disorders, and structural chromosome rearrangements prior to embryo transfer. It helps in improving embryo selection, enhances implantation rates, decreases the risk of spontaneous miscarriages, and reduces chances of transmitting hereditary diseases to offspring.

As per European Society of Human Reproduction and Embryology (ESHRE), more than 1 million ART treatment cycles are performed annually across Europe, highlighting the growing adoption of assisted reproductive technologies and the increasing need for advanced embryo genetic screening. Additionally, continuous developments in the fields of NGS and PCR technologies have resulted in enhanced precision and speed of PGT. Moreover, the awareness levels about reproductive genetics along with the expansion of fertility clinics and favorable regulations in certain nations are driving the uptake of PGT services. It is anticipated that the increase in the number of IVF cycles and the need for customized reproductive health services will drive the Preimplantation Genetic Testing Market over the coming years.

Preimplantation Genetic Testing Market- Segmentation Analysis:

The Global Preimplantation Genetic Testing Market is segmented on the basis of Product, Application, End User, Technology, and Region.

Based on Preimplantation Genetic Testing Market, By Test Type, Preimplantation Genetic Testing for Aneuploidy Testing Services held the largest market share on account of their extensive usage during IVF treatment process in order to detect any anomalies in chromosomes. Such a genetic test increases the chances of implantation, lowers risks of miscarriages, and increases chances of conception especially in case of older women. Moreover, increased use of next-generation sequencing technology has increased the efficiency and accuracy of PGT-A testing services. For example, in May 2026, GenEmbryomics Limited introduced XGEN PGT-X(TM), which is the world's first clinical grade whole genome preimplantation genetic testing solution used in IVF embryos. It was made available through the company's Early Access Partner Program in order to provide comprehensive embryo-genome sequencing at an affordable price. Furthermore, PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) Testing Services will experience high growth in the future on account of growing number of genetic testings for the screening of inherited disorders prior to embryo implantation.

Based on Application, IVF Embryo Selection accounts for the largest market share owing to the increasing number of IVF procedures worldwide and the growing emphasis on improving pregnancy success rates. Genetic Disorder Screening, Recurrent Pregnancy Loss Prevention, and Advanced Fertility Planning are also witnessing increased adoption as reproductive genetics becomes more integrated into fertility care. Based on End User, Fertility Clinics dominate the market due to the availability of specialized IVF laboratories, advanced embryo biopsy capabilities, and integrated genetic testing services. Based on Technology, Next Generation Sequencing (NGS) holds the largest market share owing to its high accuracy, scalability, and ability to simultaneously detect chromosomal abnormalities and genetic mutations, making it the preferred technology for modern preimplantation genetic testing.

Preimplantation Genetic Testing Market- Geographical Insights

Regarding the Preimplantation Genetic Testing (PGT) Market, North America occupied the largest market share due to the high adoption rate of Assisted Reproductive Technologies (ART), advanced genetic testing facilities, and the presence of prominent fertility clinics and reproductive genetics laboratories in the region. Further contributing factors are an increased understanding of genetic disorders, increasing age of mothers, and the increasing adoption of next-generation sequencing (NGS) based embryo screening for in vitro fertilization (IVF). The Centers for Disease Control and Prevention (CDC) reports that the United States is consistently performing high number of ART procedures every year due to persistent demand for IVF treatment. The CDC's National ART Surveillance System (NASS) collects data every year from about 500 fertility clinics in the U.S. It reported that about 435,426 ART cycles were performed in 2022. An increase in the number of ART procedures performed has resulted in the increasing use of PGT as part of the process, thus making North America the leading region in the market globally.

Europe is another major market due to the existence of established networks for fertility treatments, supportive regulatory environments in many countries, and ongoing technological developments in reproductive genetics. There has been an increase in the number of cases where IVF and embryo screening treatments have been used, especially in countries such as Spain, UK, Italy, and Denmark. More than one million ART treatment cycles are performed annually in Europe each year, which demonstrates that there is increased demand for IVF treatment and advanced genetic testing, which include PGT-A, PGT-M, and PGT-SR. The increasing adoption of NGS testing in fertility clinics is likely to further boost market growth in the region.

Preimplantation Genetic Testing Market- Competitive Landscape:

The Competitive landscape of the Preimplantation Genetic Testing (PGT) Market consist of the presence of specialized reproductive genetics laboratories, molecular diagnostics firms, and ART solution providers who compete by virtue of innovation in technology, expansion of their labs, and collaborative efforts. The major players include Vitrolife Group (Igenomix), CooperGenomics, Thermo Fisher Scientific Inc., Illumina, Inc., Natera, Inc., Fulgent Genetics, Genea Biomedx, Invitae Corporation, Eurofins Scientific, and Laboratory Corporation of America Holdings (Labcorp). These firms are developing NGS-based preimplantation genetic testing products, automated workflows, and larger laboratories for improving the efficiency and speed of the process. Firms are also focusing on the expansion of global laboratory networks, collaborations with fertility clinics, and use of genomic technology in IVF. This is expected to increase competition in the global Preimplantation Genetic Testing Market.

Recent Developments:

In April 2024, GenEmbryomics Limited and Progenesis Inc. entered into a strategic partnership to expand access to advanced preimplantation genetic testing for IVF patients. The collaboration combined Progenesis' laboratory capabilities with GenEmbryomics' Panacea-GenomeScreen(TM) PGT-WGS technology, enabling comprehensive whole-genome embryo screening and advancing genetic testing solutions in reproductive medicine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Vitrolife Group (Igenomix)
  • CooperGenomics (CooperSurgical)
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Labcorp)
  • Eurofins Scientific
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • BGI Genomics Co., Ltd.
  • Genea Biomedx
  • GeneDx
  • SOPHiA GENETICS
  • FUJIFILM Irvine Scientific
  • Oxford Gene Technology (Sysmex)
  • Pacific Biosciences (PacBio)
  • Merck KGaA
  • Juno Genetics
  • Progenesis, Inc.
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • PGT-A Testing Services
  • PGT-M Testing Services
  • PGT-SR Testing Services
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • IVF Embryo Selection
  • Genetic Disorder Screening
  • Recurrent Pregnancy Loss Prevention
  • Advanced Fertility Planning
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Fertility Clinics
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Microarray Technology
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Preimplantation Genetic Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preimplantation Genetic Testing Market Snippet by Product
    • 2.1.2. Preimplantation Genetic Testing Market Snippet by Application
    • 2.1.3. Preimplantation Genetic Testing Market Snippet by End User
    • 2.1.4. Preimplantation Genetic Testing Market Snippet by Technology
    • 2.1.5. Preimplantation Genetic Testing Market Snippet by Country
    • 2.1.6. Preimplantation Genetic Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Preimplantation Genetic Testing Key Market Trends

  • 3.1. Preimplantation Genetic Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preimplantation Genetic Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preimplantation Genetic Testing Market Opportunities
  • 3.4. Preimplantation Genetic Testing Market Future Trends

4. Preimplantation Genetic Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preimplantation Genetic Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preimplantation Genetic Testing Market Landscape

  • 6.1. Preimplantation Genetic Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preimplantation Genetic Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. PGT-A Testing Services
    • 7.1.3. PGT-M Testing Services
    • 7.1.4. PGT-SR Testing Services
    • 7.1.5. Others

8. Preimplantation Genetic Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. IVF Embryo Selection
    • 8.1.3. Genetic Disorder Screening
    • 8.1.4. Recurrent Pregnancy Loss Prevention
    • 8.1.5. Advanced Fertility Planning
    • 8.1.6. Others

9. Preimplantation Genetic Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Fertility Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Research Institutes

10. Preimplantation Genetic Testing Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Next Generation Sequencing
    • 10.1.3. Polymerase Chain Reaction (PCR)
    • 10.1.4. Fluorescence In Situ Hybridization (FISH)
    • 10.1.5. Microarray Technology
    • 10.1.6. Others

11. Preimplantation Genetic Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preimplantation Genetic Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preimplantation Genetic Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preimplantation Genetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preimplantation Genetic Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preimplantation Genetic Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Preimplantation Genetic Testing Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Vitrolife Group (Igenomix)
    • 12.2.2. CooperGenomics (CooperSurgical)
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. Illumina, Inc.
    • 12.2.5. Natera, Inc.
    • 12.2.6. Laboratory Corporation of America Holdings (Labcorp)
    • 12.2.7. Eurofins Scientific
    • 12.2.8. Quest Diagnostics Incorporated
    • 12.2.9. Agilent Technologies, Inc.
    • 12.2.10. Revvity, Inc.
    • 12.2.11. BGI Genomics Co., Ltd.
    • 12.2.12. Genea Biomedx
    • 12.2.13. GeneDx
    • 12.2.14. SOPHiA GENETICS
    • 12.2.15. FUJIFILM Irvine Scientific
    • 12.2.16. Oxford Gene Technology (Sysmex)
    • 12.2.17. Pacific Biosciences (PacBio)
    • 12.2.18. Merck KGaA
    • 12.2.19. Juno Genetics
    • 12.2.20. Progenesis, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기